The chart below shows the percentage of a drug company’s total sales, by region, from 2002 to 2006. Summarise the information by selecting and reporting the main features, and make comparisons where relevant.
The chart below shows the percentage of a drug company’s total sales, by region, from 2002 to 2006.
Summarise the information by selecting and reporting the main features, and make comparisons where relevant.
The bar chart compares the proportion of a drug company’s total sales in Asia, Europe and America during the period of 5 years from 2002 to 2006.
Overall, it is evident that the percentage of the total sales of this company in Asia always witnessed a significant increase after 5 years. In contrast, in the same period, there was a considerable decrease in the equivalent number in other regions after noticeable fluctuations.
In Asia, the company’s sales only accounted for a quarter of the company’s total sales, which was the lowest one. However, after seeing 2 5-percent rises in 2003 and 2004, the percentage of the company’s sales rocketed to 35 percent. In the following years, the proportion increased by 5 percent, and Asia became the most profitable place of the company since 2005, accounting for 35 percent of the total sales in 3 regions.
Meanwhile, the two other regions saw a noticeable decrease over the period. Regarding the America, the percentage of the company’s sales was the highest in 2002, at 41 percent, but in 2004 it plummeted to 27 percent, which was the lowest one in this year. Then, thanks to a slight increase to 30 percent in 2006, the contribution to the company’s sales in America was equal to the Europe’s. Similarly, the percentage of the company’s sales in Europe was 34 percent, which was higher than the Asia’s. Notably, after 2 years, the percentage of the company’s sales in Europe reached to the peak at 38% to become the most profitable region of the company. However, it then went down to 30 percent in 2006, which was equal to the America’s as aforementioned.
Phản hồi